Takeda Pharmaceutical Co., Ltd. et al v. TWi Pharmaceuticals, Inc.

Filing 130

ORDER RE CASE MANAGEMENT CONFERENCE. Signed by Judge Lucy H. Koh on 12/11/2014. (lhklc3S, COURT STAFF) (Filed on 12/11/2014)

1
2
3
4
5
UNITED STATES DISTRICT COURT
6
NORTHERN DISTRICT OF CALIFORNIA
7
SAN JOSE DIVISION
8

10

TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A.,
INC., AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,

11

Plaintiffs,

United States District Court
For the Northern District of California

9

12
13
14

v.
TWI PHARMACEUTICALS, INC.,
Defendant.

)
)
)
)
)
)
)
)
)
)
)
)
)

Case No.: 13-CV-02420-LHK
ORDER RE CASE MANAGEMENT
CONFERENCE

15
16

At the case management conference held on December 10, 2014, the Court indicated that it

17

would not allow Takeda to reassert claim 6 of the ’187 Patent. Upon further consideration, the

18

Court changed its mind, as reflected in the Court’s Case Management Order. See ECF No. 129.

19

Should TWi need to amend its invalidity contentions as a result of the Court’s decision, the Court

20

will allow TWi to do so.

21

IT IS SO ORDERED.

22

Dated: December 11, 2014

_________________________________
LUCY H. KOH
United States District Judge

23
24
25
26
27
28
1
Case Nos.: 13-CV-02420-LHK
ORDER RE CASE MANAGEMENT CONFERENCE